Asgard Therapeutics
Asgard Therapeutics is a Biotechnology Company.
Asgard Therapeutics has raised €6.0M across 1 funding round from 3 investors, most recently a Seed round in Nov 2021. Based in Lund, Sweden; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€6.0M
€6,000,000
Funding rounds
1
Investors
3
distinct backers
Active since
2021-11
latest 2021-11
Funding by year
EUR raised per yearAsgard Therapeutics — funding by year — interactive chart.
Data table
| Asgard Therapeutics — funding by year | |
|---|---|
| 2021 | €6.0M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-11-09 | Seed | €6.0M | Boehringer Ingelheim Venture Fund,Industrifonden,Novo Holdings | View deal → |
Related news
- Novo Holdings co-Leads EUR6m seed financing in Asgard Therapeuticsprivateequitywire.co.uk · 2021-11
Similar companies
same sector or countryGlobal coverage: FundingData